FDA clears first oral drug to treat postpartum depression or ‘baby blues’
HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after.
HQ Team August 3, 2023: China is grappling with a rapid increase in mpox cases, formerly known as monkeypox, prompting concerns from the.
HQ Team August 2, 2023: The key to increasing breastfeeding rates globally is to support and protect lactating mothers in the workplace, the.
HQ Team August 2, 2023: There is a shortage of prescription stimulant medications in the US due to a manufacturing delay by one.
HQ Team August 2, 2023: India’s Lupin Ltd., the eighth largest generic pharmaceutical company in the world based on revenue, has received the.
HQ Team August 1, 2023: India has ordered a shutdown of a domestic pharmaceutical firm, whose cough syrup is believed to be behind.
HQ Team August 1, 2023: The US medical research agency has opened enrollment for the second stage of trials to evaluate about four treatments.
HQ Team August 1, 2023: Quest Diagnostics, a New Jersey, US-based clinical laboratory company, has started selling the first blood testing kits for.
HQ Team July 30, 2023: A not-for-profit US company, Harm Reduction Therapeutics’s ReVive has been allowed by the FDA to market its opioid.
HQ Team July 29, 2023: A Tanzanian child under two years of age has been diagnosed with circulating vaccine-derived poliovirus type 2 (cVDPV2),.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com